A vaccinia replication system for producing recombinant hepatitis C virus.
A vaccinia replication system for producing recombinant hepatitis C virus.
复制标题
DOI:
10.3748/wjg.v10.i18.2670
复制
发表时间:
2004-09
影响因子:
4.3
通讯作者:
Ying-song Wu;Yu-xuan Feng;W. Dong;Yan-ming Zhang;Ming Li
中科院分区:
文献类型:
--
作者:
Ying-song Wu;Yu-xuan Feng;W. Dong;Yan-ming Zhang;Ming Li
AIM To develop a cell culture system capable of producing high titer hepatitis C virus (HCV) stocks with recombinant vaccinia viruses as helpers. METHODS Two plasmids were used for the generation of recombinant HCV: one containing the full-length HCV cDNA cloned between T7 promoter and T7 terminator of pOCUS-T7 vector, and the other containing the HCV polyprotein open reading frame (ORF) directly linked to a vaccinia late promoter in PSC59. These two plasmids were co-transfected into BHK21 cells, which were then infected with vTF7-3 recombinant vaccinia helper viruses. RESULTS After 5 d of incubation, approximately 3.6X10(7) copies of HCV RNA were present per milliliter of cell culture supernatant, as detected by fluorescence quantitative RT-PCR (FQ-PCR). The yield of recombinant HCV using this cell system increased 100- to 1 000- fold compared to in vitro- transcribed HCV genomic RNA or selective subgenomic HCV RNA molecule method. CONCLUSION This cell culture system is capable of producing high titer recombinant HCV.